Eli Lilly & Co |
9.83% |
UnitedHealth Group Inc |
7.80% |
AbbVie Inc |
5.69% |
Novo Nordisk A/S |
5.24% |
AstraZeneca PLC |
4.26% |
Intuitive Surgical Inc |
4.12% |
Thermo Fisher Scientific Inc |
3.86% |
Roche Holding AG |
3.71% |
Bristol-Myers Squibb Co |
3.65% |
Johnson & Johnson |
3.51% |
Abbott Laboratories |
3.33% |
Zoetis Inc |
3.00% |
Boston Scientific Corp |
2.99% |
Danaher Corp |
2.90% |
Vertex Pharmaceuticals Inc |
2.43% |
Sanofi |
2.34% |
Gilead Sciences Inc |
2.24% |
CSL Ltd |
2.16% |
McKesson Corp |
1.68% |
Neurocrine Biosciences Inc |
1.52% |
Merck & Co Inc |
1.51% |
IDEXX Laboratories Inc |
1.46% |
Lonza Group AG |
1.44% |
Mettler-Toledo International Inc |
1.41% |
Cooper Cos Inc |
1.27% |
ARGENX SE - ADR |
1.20% |
Edwards Lifesciences Corp |
1.19% |
Stryker Corp |
1.15% |
Alcon AG |
1.13% |
Centene Corp |
1.07% |
SPDR S&P Biotech ETF |
1.01% |
Teleflex Inc |
0.98% |
Straumann Holding AG |
0.97% |
Coloplast A/S |
0.96% |
Royalty Pharma PLC |
0.88% |
Amplifon SpA |
0.87% |
Illumina Inc |
0.86% |
AptarGroup Inc |
0.75% |
Sartorius AG |
0.73% |
Align Technology Inc |
0.71% |
Neogen Corp |
0.55% |
Option Care Health Inc |
0.45% |
Asahi Intecc Co Ltd |
0.45% |
Newamsterdam Pharma Co NV |
0.32% |
JMDC Inc |
0.22% |
CARIS LIFE SCIENCES, INC |
0.06% |
MSILF GOVERNMENT PORTFOLIO |
0.04% |